STOPPCog 标准:认知脆弱老年人处方精简共识
本研究通过德尔菲共识法验证了 STOPPCog 标准,该标准用于识别认知脆弱老年人中的潜在不适当用药。九名专家经两轮验证后,从初始 25 条标准中确定 23 条,分属六个亚组。STOPPCog 可辅助医生在此类患者中实施处方精简。
要点
- STOPPCog 包含 23 条标准,分属六个与认知脆弱老年人用药相关的亚组。
- 标准涵盖抗胆碱能药、镇静药、慢性疼痛用药及痴呆无效用药等。
- 该工具或可辅助医生在认知脆弱老年人群中开展处方精简。
核心结论
- STOPPCog 包含 23 条与认知脆弱老年人潜在不适当用药相关的标准。
- STOPPCog 可能有助于医生在该患者人群中实施处方精简。
研究设计与样本
- 研究采用德尔菲共识调查法,由学术老年科医生、老年精神科医生、全科医生和临床药师组成的专家小组参与。
- 研究地点为爱尔兰,共九名专家组成员参与。
主要发现
- 所有专家组成员均完成了两轮德尔菲共识验证。
- 最终列表包含 23 条标准,分为六个亚组。
关键数值与推荐
- 标准纳入条件为:中位值 1 或 2(强烈同意/同意)且第 25 百分位值 ≤2。
- 六个亚组包括:每日服用抗胆碱能药物;每日服用镇静药物;可能加重 α-突触核蛋白病理患者精神病性症状的药物;慢性疼痛用药;每日服用无痴呆疗效证据的药物;晚期痴呆(临床痴呆评定量表 3.0)无明确获益的药物。
临床怎么用
- STOPPCog 可用于辅助医生识别认知脆弱老年人中的潜在不适当用药并指导处方精简。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To validate STOPPCog, a list of explicit criteria for potentially inappropriate medication use in cognitively vulnerable older adults. DESIGN: A Delphi consensus survey of an expert panel comprising academic geriatricians, old age psychiatrists, general practitioners, and clinical pharmacists. SETTING: Ireland. SUBJECTS: Nine panellists. METHODS: STOPPCog criteria were initially created by the authors based on clinical experience and literature appraisal. Criteria were organised according to drug/drug class. Using Delphi consensus methodology, panellists ranked their agreement with each criterion on a 5-point Likert scale and provided written feedback. Criteria with a median value of 1 or 2 (strongly agree/agree) and a 25th centile value of ≤2 were included in the final list. RESULTS: All panellists completed two Delphi consensus validation rounds. Twenty-five criteria were proposed initially, twenty were accepted. One criterion was rejected (multi-vitamin supplements), and four criteria were rephrased (two of these were combined to one criterion for greater clarity). The final list comprised 23 criteria that are arranged in six subgroups i.e. (i) drugs with anticholinergic properties taken daily; (ii) drugs with sedative properties taken daily; (iii) drugs that may exacerbate psychotic symptoms in patients with alpha-synuclein pathology; (iv) drugs used for chronic pain; (v) drugs without proven efficacy for dementia taken daily; (vi) drugs that are of no proven benefit in advanced stage dementia i.e. clinical dementia rating of 3.0 where palliation may be appropriate. CONCLUSION: STOPPCog comprises 23 criteria relating to medications that are potentially inappropriate in cognitively vulnerable older adults. STOPPCog may assist physicians in deprescribing medications in this patient population.
引用
- McGettigan S, Curtin D, O'Mahony D, et al. Deprescribing in cognitively vulnerable older people: development and validation of STOPPCog criteria. Age Ageing. 2025. PMID: 39902992. doi:10.1093/ageing/afaf014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。